From Science Week: Innovative arenas create collaboration for the city of the future

In a panel discussion during Science Week on February 1, it was discussed how innovative neutral arenas are central to the development of the smart and knowledge-intensive city.

Flemingsberg Science CEO Johnny Högberg participated together with a panel consisting of Sophia Sundberg, CEO, Barkaby Science, Peter Dobers, Professor of Business Administration with a focus on sustainable development and collaboration, Södertörn University, Johan Zachrisson, Business Development Manager, Fabege and Anton Västberg, Development Director, Region Stockholm. All under the guidance of moderator Lydia Capolicchio.

Watch on Youtube.

Sprint Bioscience in billion-kronor deal to develop new cancer drug

Sprint Bioscience has licensed its VADA cancer programme to US-based Day One Biopharmaceuticals. The deal is Sprint Bioscience’s largest to date and could be worth around SEK 3.4 billion. In the next two years, the two companies will take the steps towards clinical testing of a new cancer drug.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2023-02-02T13:42:54+01:00
Go to Top